Skip to main content
Swing Capital

Acutaas Chemicals Ltd

NSE: ACUTAAS BSE: 543349Pharma

Ami Organics Limited is one of the leading research and development-driven manufacturers of specialty chemicals. The company manufactures different types of Advanced Pharmaceutical Intermediates and Active Pharmaceutical Ingredients (API) for New Chemical Entities, and materials for agrochemicals and fine chemicals.[1]

₹2,803
52W: ₹1059 — ₹2850
PE 62.7 · Book ₹204 · +1274% vs book
Market Cap₹22,952 Cr
Stock P/E62.7Price to Earnings
ROCE32.8%Return on Capital
ROE24.6%Return on Equity
Div. Yield0.05%Face Value ₹5

Strengths

  • +Company is almost debt free.
  • +Company is expected to give good quarter
  • +Company has delivered good profit growth of 46.3% CAGR over last 5 years

Weaknesses

  • −Stock is trading at 13.6 times its book value
  • −Promoter holding has decreased over last 3 years: -6.75%

Shareholding Pattern

Promoters32.66%
FIIs19.48%
DIIs19.6%
Public28.24%
CategoryJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Promoters35.98%35.97%▼0.035.96%▼0.035.96%32.66%▼3.332.66%32.66%32.66%
FIIs12.93%13.87%▲0.915.52%▲1.716.48%▲1.016.94%▲0.516.84%▼0.116.67%▼0.219.48%▲2.8
DIIs14.81%19.93%▲5.120.23%▲0.318.31%▼1.922.38%▲4.122.59%▲0.221.7%▼0.919.6%▼2.1
Public36.28%30.24%▼6.028.27%▼2.029.22%▲0.928%▼1.227.89%▼0.128.96%▲1.128.24%▼0.7

Financial Statements

MetricDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales162220171244271304206305391422
Expenses138180145195204220155209237241
Operating Profit2440264867845197154181
OPM %15%18%15%20%25%28%25%32%39%43%
Net Profit1632143845634573112137
EPS ₹2.134.351.684.65.537.675.458.913.6316.74

AI Insights

Revenue Trend

Mar 2026 revenue at ₹1,324Cr, up 33.7% YoY. OPM at 36%.

Debt Position

Borrowings at ₹32Cr. Debt-to-equity ratio: 0.02x. Healthy balance sheet.

Capex Cycle

CWIP at ₹228Cr (38% of fixed assets). Significant capex underway — growth runway building.

Institutional Flow

DIIs: 19.6% (+14.48pp change). FIIs: 19.48% (+12.75pp change). Promoters hold 32.66%.

Margin & Efficiency

ROCE improving from 0% (Mar 2017) to 33% (Mar 2026). Working capital days: 116.

Valuation

PE 62.7x with 32.8% ROCE. Price is 1274% above book value of ₹204. Dividend yield: 0.05%.

Recent Announcements